DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 124 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2017. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,370,000 | -8.4% | 69,000 | -13.8% | 0.02% | -11.5% |
| Q4 2017 | $1,496,000 | -71.4% | 80,000 | -67.1% | 0.03% | -71.4% |
| Q3 2017 | $5,225,000 | +3.1% | 243,000 | -53.7% | 0.09% | -4.2% |
| Q2 2017 | $5,066,000 | +385.7% | 525,000 | +634.3% | 0.10% | +251.9% |
| Q2 2016 | $1,043,000 | -23.8% | 71,500 | 0.0% | 0.03% | -20.6% |
| Q1 2016 | $1,368,000 | -56.7% | 71,500 | -44.5% | 0.03% | -56.4% |
| Q3 2015 | $3,161,000 | +159.5% | 128,800 | +147.7% | 0.08% | +212.0% |
| Q2 2015 | $1,218,000 | – | 52,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |